Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:04 AM
Ignite Modification Date: 2025-12-25 @ 2:04 AM
NCT ID: NCT05105360
Eligibility Criteria: Inclusion Criteria: : histological proven primary gastric adenocarcinoma * no evidence of other distant metastasis * R0 resection * laparoscopic or robotic gastrectomy * and reconstructed by Roux-en-Y reconstruction or the Billroth II procedure * patient with appropriate conditions of activity; 0 or 1 on Eastern Cooperative Oncology Group (ECOG) scale * patient who have not previously received chemotherapy or radiation treatment in the abdomen. * patinet who signed the consent form * cTNM stage I or II or III Exclusion Criteria: * active double cancer (synchronous and metachronous double cancer within 5 disease-free years), * carcinoma in situ, * open gastrectomy, * reconstructed by Billroth I procedure, * gastric cancer recurrence, ;a history of gastrectomy. ; * a patient who has the history of abdominal surgery except laparoscopic appendectomy and gallbladder resection, and laparoscopic gynecologic surgery due to benign disease, and Cesarean section. * a patient who need co-ordination for other organs in preoperative examination (However, laparoscopic cholecystectomy is included in the selection criteria due to gallbladder polyps, and gallbladder disease). * Pregnant women, lactating women * a patient with mental illness (a person diagnosed with mental illness in medical records) * a patient who are taking corticosteroid whole-body (including herbal medicine) * a patient who has an uncontrolled history of angina or myocardial infarction within six months of the study; * uncontrolled hypertension * a patient who has a serious respiratory disease that requires continuous oxygen therapy;
Healthy Volunteers: False
Sex: ALL
Minimum Age: 20 Years
Study: NCT05105360
Study Brief:
Protocol Section: NCT05105360